(Q52025987)

20 April 2018

title

Seamlessly expanding a randomized phase II trial to phase III. (English)

1 reference

20 April 2018

main subject

phase III clinical trial

0 references

phase II clinical trial

0 references

author name string

Lurdes Y T Inoue

series ordinal

1

1 reference

20 April 2018

Peter F Thall

series ordinal

2

1 reference

20 April 2018

Donald A Berry

series ordinal

3

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 December 2002

1 reference

20 April 2018

published in

Biometrics

1 reference

20 April 2018

volume

58

1 reference

20 April 2018

issue

4

1 reference

20 April 2018

page(s)

823-831

1 reference

20 April 2018

maintained by WikiProject

WikiProject Mathematics

0 references

cites work

A case for Bayesianism in clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2002.00823.X

Decision making during a phase III randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2002.00823.X

Surrogate end points in clinical trials: are we being misled?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2002.00823.X

Sampling-Based Approaches to Calculating Marginal Densities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2002.00823.X

A stochastic model for censored-survival data in the presence of an auxiliary variable

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2002.00823.X

Using auxiliary variables for improved estimates of survival time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2002.00823.X

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2002.00823.X

Comparing the survival of two groups with an intermediate clinical event

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2002.00823.X

A Multiple Testing Procedure for Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2002.00823.X

Optimal two-stage designs for phase II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2002.00823.X

Decision theoretic designs for phase II clinical trials with multiple outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0006-341X.2002.00823.X

10.1111/J.0006-341X.2002.00823.X

21 January 2018

Identifiers

DOI

1 reference

20 April 2018

1 reference

20 April 2018